Halozyme Therapeutics Names William Fallon Vice President, Manufacturing & Operations FinanzNachrichten
SAN DIEGO, Nov. 8 /PRNewswire-FirstCall/ -- Halozyme Therapeutics, ( Nachrichten ) Inc. , a biopharmaceutical company developing and commercializing recombinant human enzymes, today announced that William Fallon has been named Vice President, Manufacturing&Operations.
Symphogen Appoints Christian Meyer Vice President of Clinical Development RedNova
Symphogen announced today that Christian Meyer, M.D., Ph.D., has been appointed Vice President of Clinical Development. In this role, Dr. Meyer will lead Symphogen's clinical development activities for its portfolio of recombinant polyclonal antibody product candidates and programs.
Local earnings Deseret Morning News
Several companies, including some based in Utah or with ties to the state, reported quarterly financial results on Wednesday.
BTG in the black at half way stage ShareCast
LONDON (SHARECAST) - Medical innovations group BTG moved into profit Thursday following strong progress during the first half, with increasing royalty revenues exceeding reduced operating costs.
Dendreon Announces Preliminary Results From PROTECT P-11 Study Medical News Today
Dendreon Corporation (Nasdaq: DNDN) today announced preliminary results from its ongoing PROTECT (P-11) clinical trial for PROVENGE(R) (sipuleucel-T) in patients with non- metastatic androgen-dependent (hormone sensitive) prostate cancer. [click link for full article]
Merck's Gardasil added to CDC vaccines for children PharmaBiz
Merck & Co., Inc. announced that the US Centers for Disease Control and Prevention (CDC) has added Merck's cervical cancer vaccine, Gardasil [Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine] to the CDC's Vaccines for Children (VFC) contract for girls and women aged 9 to 18.
Vaccine-producing 'Plant-factories' Science Daily
A research team has discovered a new route for the transport of proteins in plant cells, a discovery that will enable the biotechnological design of plant factories.
Progenics Pharmaceuticals Reports Third Quarter 2006 Results Business Wire via Yahoo! Finance
TARRYTOWN, N.Y.----Progenics Pharmaceuticals, Inc. today announced its results of operations for the third quarter, and the first nine months, ended September 30, 2006.
MedImmune to Sell CytoGamR to ZLB Behring FinanzNachrichten
GAITHERSBURG, Md., Nov. 8 /PRNewswire-FirstCall/ -- MedImmune, ( Nachrichten / Aktienkurs ) Inc. today announced its intent to sell CytoGam(R) (cytomegalovirus immune globulin intravenous (human)) to ZLB Behring.
NPS Pharmaceuticals Reports Third Quarter and Nine Month Results FinanzNachrichten
PARSIPPANY, N.J., Nov. 8 /PRNewswire-FirstCall/ -- NPS Pharmaceuticals, ( Nachrichten ) Inc. today reviewed recent corporate developments, reported its operating and financial results for the three and nine months ended September 30, 2006, and reiterated its previous financial guidance.

Recombinant Capital
Subscription-based, online, database resources for biotech enterprises, also offering individual consultation.
Recombinant DNA Chapter Directory
Preparing probe, cloning into plasmids, complementarity and hybridization, gel electrophoresis, transfer to solid support and blotting variants, blocking,
An Introduction to Recombinant DNA
Recombinant DNA is the general name for taking a piece of one DNA, and The most common recombinant process involves combining the DNA of two
Recombinant DNA and Gene Transfer
Recombinant DNA and Gene Tranfer. Latest News · NIH Guidelines for Research Involving Recombinant DNA Molecules · Compliance Reminder
NIH Guidelines--Table of Contents
Recombinant DNA Molecules. April 2002. Effective June 24, 1994, Published in Federal Register, July 5, 1994 (59 FR 34496) Amendment Effective July 28, 1994,

An Introduction to Recombinant DNA
Recombinant DNA is the general name for taking a piece of one DNA, and The most common recombinant process involves combining the DNA of two
Recombinant DNA and Gene Transfer
Recombinant DNA and Gene Tranfer. Latest News · NIH Guidelines for Research Involving Recombinant DNA Molecules · Compliance Reminder
NIH Guidelines--Table of Contents
Recombinant DNA Molecules. April 2002. Effective June 24, 1994, Published in Federal Register, July 5, 1994 (59 FR 34496) Amendment Effective July 28, 1994,
Recombinant DNA Technology
In this problem set, you will learn about some of the basic techniques of recombinant DNA, and how recombinant DNA technology is applied to human health.
Recombinant DNA Tutorials
Bacterial Genetics/Recombinant DNA. Understand what plasmids are and how Understand how restriction endonucleases are used to create recombinant DNA
Speaking the Language of Recombinant DNA
The result is an edited, or recombinant, DNA molecule. When this recombinant plasmid DNA is inserted into E. coli, the cell will be able to process the
Recombinant Media Labs, San Francisco
We are currently ramping up on developing our site with excerpts from recent presentations and further information regarding private scheduled tours of the
PROTOCOLS FOR RECOMBINANT DNA ISOLATION, CLONING, and SEQUENCING
PROTOCOLS FOR RECOMBINANT DNA ISOLATION, CLONING, and SEQUENCING. edited by Bruce A. Roe Judy S. Crabtree and Akbar S. Khan Department of Chemistry and